about
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancerThe ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancerPromoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancerPrognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancerWnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumoursPromoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancerBreast cancer epigenetics: from DNA methylation to microRNAsAberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosisTight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.Characteristics of triple-negative breast cancerEpigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer.Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening.Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3.Taxane resistance in breast cancer: a closed HER2 circuit?Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.If there is no overall survival benefit in metastatic breast cancer: does it imply lack of efficacy? Taxanes as an example.Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives.Epigenetic biomarker to support classification into pluripotent and non-pluripotent cells.Paradox of sonic hedgehog (SHH) transcriptional regulation: Alternative transcription initiation overrides the effect of downstream promoter DNA methylation.The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.[Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system.Histochemical detection of platelet esterase activity in the bone marrow postmortem: can megakaryocytes serve as indicators for time since death?[Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer]Biosynthesis of phytochelatins in the fission yeast. Phytochelatin synthesis: a second role for the glutathione synthetase gene of Schizosaccharomyces pombe.Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer.[Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation].Minimizing the exposure to UV light when extracting DNA from agarose gelsPost-mortem analysis of bone marrow osteoclasts using tartrate-resistant acid phosphatase staining: does histochemistry work and correlate with time since death?RNA expression analysis on formalin-fixed paraffin-embedded tissues in TMA format by RNA in situ hybridization
P50
Q21195213-ED0ADA1D-B2CD-456B-97B3-010D5CDC9FABQ21195217-EDEC3781-F5B6-47C1-A179-E96FC4FD959DQ21245721-506EB0D5-16C0-499B-887E-D078D3D23DEAQ21260388-39312BE9-8025-4301-A2DC-ABCC10178547Q22000774-76FF204C-FC8C-4B3C-BBF8-FFF2174E1B1DQ24652213-1D283476-FFF7-449B-9F67-FCA184F1022FQ27694164-38CBED97-3664-45A9-9585-383AC0BE874FQ28294866-CF773629-43B4-43AC-80CF-99C107D8EE0BQ33318574-B99C1325-5689-466C-BFB4-141A6600A135Q34479003-041ABB5F-D012-40B2-84C4-6E98B74CCB32Q34532204-78FE423F-8913-4390-B28B-C8441A25AC9FQ34763742-64BC14A2-4FB6-4B5D-9EF8-B519421568D4Q36903254-CAE2258D-702D-4875-B2F6-11D330471DCFQ36903459-19C5FCB7-DBC3-4B81-985F-7F850E4663F3Q37943574-0092E8DE-081C-48D8-832E-C8EC83344414Q37979001-105FE40E-3391-4CD6-BFDF-3BDD4DA24FF8Q38002668-DE2270A3-40A8-447B-93FC-B140490AF73AQ38015540-F75503FF-1229-4445-A634-2AF2DA18236BQ38274934-159C8086-B6B4-41B4-AB38-074F1D77D86FQ38901846-3C99E372-D9DD-4E8C-914D-41BC11B716C3Q39581759-601AE01C-B29C-46C4-A465-F0FD3D171412Q40102564-5734BDED-02EB-4FBB-9335-3077294FA448Q43566926-7DB5F954-DC73-4571-9C0E-D1D92D2C1F7CQ43649205-06A02A7F-F6ED-4104-9CDA-AF3ACEF45CF8Q45236831-61546A29-693D-49B0-89C3-CAE67B63FCD6Q46884459-F7A56780-8A7D-49E5-9502-5377CDADB1A7Q47969028-CE15FF12-8406-49CD-96E3-72374512D8CEQ53335862-E564FDDD-8F6B-4B80-A25A-6038278F8675Q54347333-31C7F539-B2C0-4363-AE89-957B64D5C794Q54514870-BA8A981A-E496-409F-B0D6-21C8C6CBBD8EQ77481391-29C63116-5065-42FB-9C7A-9B249244F3B5Q84660641-8171E48A-9948-49D3-A659-38938423F92EQ84682946-6E5804BC-FCAC-4744-BEA8-91EEA050E61B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jürgen Veeck
@ast
Jürgen Veeck
@en
Jürgen Veeck
@es
Jürgen Veeck
@fr
Jürgen Veeck
@nl
Jürgen Veeck
@sl
type
label
Jürgen Veeck
@ast
Jürgen Veeck
@en
Jürgen Veeck
@es
Jürgen Veeck
@fr
Jürgen Veeck
@nl
Jürgen Veeck
@sl
prefLabel
Jürgen Veeck
@ast
Jürgen Veeck
@en
Jürgen Veeck
@es
Jürgen Veeck
@fr
Jürgen Veeck
@nl
Jürgen Veeck
@sl
P1053
B-9256-2008
P106
P1153
23989522300
P21
P31
P3829
P496
0000-0002-2952-6159
P569
2000-01-01T00:00:00Z